These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
66 related articles for article (PubMed ID: 638315)
21. Ouabain as an amplifier of mineralocorticoid-induced hypertension. Sekihara H; Yazaki Y; Kojima T Endocrinology; 1992 Dec; 131(6):3077-82. PubMed ID: 1446641 [TBL] [Abstract][Full Text] [Related]
22. Enhanced hypotensive effects of the essential oil of Ocimum gratissimum leaves and its main constituent, eugenol, in DOCA-salt hypertensive conscious rats. Interaminense LF; Leal-Cardoso JH; Magalhães PJ; Duarte GP; Lahlou S Planta Med; 2005 Apr; 71(4):376-8. PubMed ID: 15856420 [TBL] [Abstract][Full Text] [Related]
23. Coronary vascular reactivity is improved by endothelin A receptor blockade in DOCA-salt hypertensive rats. Giulumian AD; Pollock DM; Clarke N; Fuchs LC Am J Physiol; 1998 Jun; 274(6):R1613-8. PubMed ID: 9608015 [TBL] [Abstract][Full Text] [Related]
24. Blood pressure versus direct mineralocorticoid effects on kidney inflammation and fibrosis in DOCA-salt hypertension. Klanke B; Cordasic N; Hartner A; Schmieder RE; Veelken R; Hilgers KF Nephrol Dial Transplant; 2008 Nov; 23(11):3456-63. PubMed ID: 18515791 [TBL] [Abstract][Full Text] [Related]
25. 5-HT2B-receptor antagonist LY-272015 is antihypertensive in DOCA-salt-hypertensive rats. Watts SW; Fink GD Am J Physiol; 1999 Mar; 276(3):H944-52. PubMed ID: 10070078 [TBL] [Abstract][Full Text] [Related]
26. [Antihypertensive effect of arotinolol (S-596), a new adrenergic beta blocking agent, on experimental hypertension]. Hara Y; Nakahara H; Miyagishi A; Nakatani H Nihon Yakurigaku Zasshi; 1983 Aug; 82(2):103-16. PubMed ID: 6198264 [TBL] [Abstract][Full Text] [Related]
27. Effect of long-term administration of two beta-blocking agents on myocardial structure in spontaneously hypertensive rats. Monopoli A; Ongini E; Lagrasta C; Ricci R; Olivetti G Arch Int Pharmacodyn Ther; 1991; 313():129-39. PubMed ID: 1840090 [TBL] [Abstract][Full Text] [Related]
28. Role of opioidergic component in the antihypertensive effect of clonidine. Chauhan PA; Hemavathi KG; Gulati OD Indian J Physiol Pharmacol; 1983; 27(4):305-10. PubMed ID: 6086521 [TBL] [Abstract][Full Text] [Related]
29. Emblica officinalis exerts antihypertensive effect in a rat model of DOCA-salt-induced hypertension: role of (p) eNOS, NO and oxidative stress. Bhatia J; Tabassum F; Sharma AK; Bharti S; Golechha M; Joshi S; Sayeed Akhatar M; Srivastava AK; Arya DS Cardiovasc Toxicol; 2011 Sep; 11(3):272-9. PubMed ID: 21748534 [TBL] [Abstract][Full Text] [Related]
30. Renal function contributes to antihypertensive effect of vasopressin in DOCA-salt but not spontaneous hypertension. Wang H; McNeill JR Am J Physiol; 1994 Nov; 267(5 Pt 2):H1842-50. PubMed ID: 7977814 [TBL] [Abstract][Full Text] [Related]
31. Nylidrin: a potent anti-hypertensive agent in hypertensive rats. Yen TT; Pearson DV Res Commun Chem Pathol Pharmacol; 1979 Jan; 23(1):11-28. PubMed ID: 441505 [TBL] [Abstract][Full Text] [Related]
32. Antihypertensive activity of alacepril in spontaneously hypertensive rats and deoxycorticosterone acetate-salt hypertensive rats and dogs. Takeyama K; Minato H; Fukuya F; Kawahara S; Hosoki K; Kadokawa T Arzneimittelforschung; 1985; 35(10):1507-12. PubMed ID: 3000390 [TBL] [Abstract][Full Text] [Related]
33. Twice-daily pindolol and alprenolol in essential hypertension of moderate severity. Hartikainen M; Heikkilä J Ann Clin Res; 1976 Apr; 8(2):85-92. PubMed ID: 779590 [TBL] [Abstract][Full Text] [Related]
34. Prolonged effects of p-chlorophenylalanine on the blood pressure of conscious normotensive and DOCA/saline hypertensive rats. Buckingham RE; Hamilton TC; Moore RA Br J Pharmacol; 1976 Jan; 56(1):69-75. PubMed ID: 130177 [TBL] [Abstract][Full Text] [Related]
35. Chronic effects of bunitrolol and pindolol on blood pressure, heart rate, vascular lesions, and plasma renin activity in hypertensive rats. Hasegawa Y; Watanabe TX; Kawashima K; Sokabe H; Saito K Jpn J Pharmacol; 1982 Aug; 32(4):742-5. PubMed ID: 6127427 [No Abstract] [Full Text] [Related]
36. Chronic treatment with mianserin prevents DOCA-salt hypertension in rats--evidence for the involvement of central 5-HT2 receptors. Silva AL; Cabral AM; Abreu GR; Pires JG; Bissoli NS; Ramage AG Eur J Pharmacol; 2005 Aug; 518(2-3):152-7. PubMed ID: 16014306 [TBL] [Abstract][Full Text] [Related]
37. Antihypertensive effect of nuatigenin-3-O-β-chacotriose from Solanum sisymbriifolium Lam. (Solanaceae) (ñuatî pytâ) in experimentally hypertensive (ARH+DOCA) rats under chronic administration. Ibarrola DA; Hellión-Ibarrola MC; Montalbetti Y; Heinichen O; Campuzano MA; Kennedy ML; Alvarenga N; Ferro EA; Dölz-Vargas JH; Momose Y Phytomedicine; 2011 Jun; 18(8-9):634-40. PubMed ID: 21353509 [TBL] [Abstract][Full Text] [Related]
38. Increased cardiovascular responsiveness to GABAergic stimulation in DOCA-salt hypertensive rats. Magrì V; Trimarchi GR; Quattrone G; Squadrito F; Di Giorgio RM; Costa G; Caputi AP Res Commun Chem Pathol Pharmacol; 1984 Jul; 45(1):107-18. PubMed ID: 6433410 [TBL] [Abstract][Full Text] [Related]
39. Discrepancy between central sympathoinhibitory action and peripheral hemodynamic effects of pindolol in anesthetized rats. Yoshioka M; Togashi H; Matsumoto M; Tochihara M; Minami M; Saito H Hokkaido Igaku Zasshi; 1988 Nov; 63(6):957-62. PubMed ID: 3248773 [TBL] [Abstract][Full Text] [Related]